Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for BUPROPION HYDROCHLORIDE
- Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)
- Voxelotor CYP and Transporter Cocktail Interaction Study
- Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion
- A Study to Assess the Effect of BMS-986419 on the Single Dose Drug Levels of Probe Substrates in Healthy Participants
- Cannabidiol for Bipolar Depression (CBD-BD)
- Improving Smoking Abstinence Outcomes in the African American Community Through Extended Treatment
- Effects of Paroxetine on Cardiovascular Function in Septic Patients
- VA Aripiprazole vs Esketamine for Treatment Resistant Depression
- SMART Trial to Predict Anhedonia Response to Antidepressant Treatment
- RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)
- Lamotrigine and Bupropion for Meniere's Disease
- Integrating Tobacco Use Cessation Into HIV Care and Treatment in Kisumu County, Kenya
- The Effects of Combination Zonisamide and Bupropion on Switching to an Electronic Cigarette
- Repurposing of Dextromethorphan as an Adjunct Therapy in Patients With Major Depressive Disorder
- SINGLE DOSE CROSSOVER COMPARATIVE BIOAVAILABILITY STUDY OF BUPROPION HCl MR TABLET 300 MG
- Pharmacological and Behavioral Treatment After Bariatric Surgery
- Impact of Silymarin Dosages to Decrease Drug-induced Elevated Liver Enzymes Compared to Placebo
- An Evaluation of AXS-05 for the Treatment of TRD in Treatment-Adherent Patients
- Use of Mysimba in Patients With Weight Regain After Bariatric Surgery
- A Study in Healthy Men and Women to Test Whether BI 1358894 Influences the Amount of Bupropion in the Blood
- Effect of Smoking Cessation on Tuberculosis Treatment Outcomes
- Drug-Drug Interaction (DDI) Study in Healthy Volunteers
- Study of Exposure to Substances Prohibited by the World Anti-Doping Agency in Healthy Volunteers.
- A Drug-drug Interaction Study Of Fluzoparib (SHR3162) on Patients With Recurrent Ovarian Cancer
- Drug Drug Interaction Study With Lu AG06466 in Young Healthy Men
- A Drug Interaction Study of Danicopan
- Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use
- Drug-drug Interaction of SHR3680 With Repaglinide and Bupropion
- 7-day Simvastatin and Emotional Processing
- Drug-drug Interaction Study of KL1333 in Healthy Subjects
- Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment
- Comparing a Virtual vs. Face to Face Weight Management Program Using Phentermine for Patients With Overweight or Obesity
- Pharmacological and Behavioral Treatments After Bariatric Surgery: Maintenance Treatment (Stage 2a)
- Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
- Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)
- Evaluating Contrave for Weight Maintenance in Adults With BMI >= 27 Kg/m2, After 6 Month Behaviour Modification Program.
- A Trial Evaluating the Effectiveness of Contrave in Patients Who Have Weight Recidivism Following Bariatric Surgery
- Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
- Relapse Prevention in Stimulant Use Disorder
- Study of ALXN1840 on the Metabolism of a CYP2B6 Substrate in Healthy Participants
- Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study
- A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV
- Efficacy of Online CBT for GAD Compared to Pharmaceutical Interventions
- A Study to Evaluate the Effect of Fluconazole, Bupropion, or Itraconazole on the Drug Levels and Safety of BMS-986235
- A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Repaglinide or Bupropion in Advanced Solid Tumor Subjects
- eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk
- Combination of Novel Therapies for CKD Comorbid Depression
- Investigating N-3 Fatty Acids to Prevent Neonatal Tobacco-related outcomeS
- Naltrexone/Bupropion (Mysimba) to Optimize Weight Outcomes After Obesity Surgery
- Zonisamide/Bupropion Effects on Switching to Electronic Cigarettes
- Leveraging EEG for Antidepressant Prediction With Duloxetine and Bupropion
- Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits
- Varenicline and Bupropion for Alcohol Use Disorder
- Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH)
- Bupropion for the Prevention of Postpartum Smoking Relapse
- Multimodal Cue Exposure Therapy for Smoking Cessation
- Bupropion in Reducing Cancer Related Fatigue in Stage I-III Breast Cancer Survivors
- Promoting Enhanced Pharmacotherapy Choice Through Immunomarkers Evaluation in Depression
- CPT-SMART for Treatment of PTSD and Cigarette Smoking
- 7-day Atorvastatin and Emotional Processing
- VIP Smoking Cessation Intervention for Adults With Serious Mental Illness
- Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Medication Change for Non-Responders
- Investigation of Genetic Predictors of the Response to Selective Serotonin Re-uptake Inhibitors (SSRI) Treatment
- Bupropion and Cigarette-Related Cues in Smokers
- Individualizing Pharmacotherapy for African American Smokers
- Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors
- A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant Depression
- Varenicline for Smoking Cessation in Hospitalized Patients With Psychiatric Disorders
- Effectiveness of Combination Varenicline and Oral Nicotine Replacement Therapy (COMBO)
- A Prediction Study of Multiple Indexes of the Effect of Different Mechanisms of Antidepressants Treatment on Depression
- Assessing Symptomatic Clinical Episodes in Depression
- Effects of Mediterranean Diet and Naltrexone/Bupropion Treatment in Obese Breast Cancer Patients
- Effects of LRYGB on Pharmacokinetics of Nine CYP Probe Drugs
- Varenicline OTC Trial on Efficacy and Safety
- So-Lo-Mo Intervention Applied to the Smoking Cessation Process
- Efficacy and Mechanisms of Naltrexone+Bupropion for Binge Eating Disorder
- AXS-05 Phase II Trial on Smoking Behavior
- Assessment of and Treatment Applied to Food Addiction in a Rural Healthy Behaviors Clinic
- Bupropion Stereoselective Disposition and CYP2D6-mediated Drug Interactions in Healthy Volunteers
- Efficacy of the Use of Genetic Markers in the Choice of the Pharmacological Treatment of Smoking (GENTSMOKE)
- Smoking Cessation Interventions for People Living With HIV in Nairobi, Kenya
- High Dose Bupropion for Smoking Cessation
- A Study to Evaluate the Effect of Ibrutinib on the Pharmacokinetics of Oral Contraceptives, CYP2B6, and CYP3A4 Substrates in Female Participants With B Cell Malignancy
- Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor
- Add-on to Cognitive, Event-Related Potentials (ERP) and Electroencephalogram (EEG) Asymmetry in Affective Disorders
- Assess the Influence of Cenobamate on the PK of Cytochrome P450 (CYP) Probe Drugs as a Means of Predicting Drug-drug Interactions
- Addressing Dementia Via Agitation-Centered Evaluation
- Smoking Cessation After Acute Coronary Syndrome
- A Phase 1 Study to Evaluate Safety, Tolerability, PK, and PK Interactions of TBA-7371
- Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
- Buproprion for Binge Drinking
- Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
- A Study of Diagnosis and Treatment of Depression Based on Biological Evidence of Dopamine Reward Pathway
- Study Assessing the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects With Cystic Fibrosis
- Naltrexone-Bupropion Versus Placebo-Bupropion for Weight Loss in Schizophrenia
- Effect of Bupropion on Seizure Threshold in Depressed Patients
- A Study to Evaluate the Safety and Efficacy of TS-121 as an Adjunctive Treatment for Major Depressive Disorder
- Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder
- Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Specialist Treatment
- Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Maintenance Therapy
- Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Acute Treatment
- Mobile Contingency Management for Concurrent Abstinence From Alcohol and Smoking
- Optimizing Outcomes of Treatment-Resistant Depression in Older Adults
- Varenicline for "Gradual" vs. "Abrupt" Smoking Cessation in Low-motivated COPD Smokers
- Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
- Smoking Treatment and Exercise Program for Underserved Populations (STEP UP)
- Mobile Contingency Management for Marijuana and Tobacco Cessation
- A Trial of Dextromethorphan for Treatment of Major Depressive Disorder
- Extended Varenicline Treatment for Smoking Among Cancer Patients
- An Open Label Trial of Bupropion and Naltrexone for Binge Drinking
- Study to Evaluate the Effect of Naltrexone and Bupropion Combination on the Pharmacokinetics of Metformin in Healthy Participants
- Effect of Smoking Cessation on Clinical and Microbiological Outcomes of the Non-surgical Periodontal Therapy
- A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive Disorder
- Naltrexone and Bupropion Combination on Obese,Smoking Patients With Schizophrenia
- Study to Evaluate the Effect of Naltrexone and Bupropion Extended-Release Combination on Cardiac Repolarization in Healthy Participants
- A Study to Evaluate Pharmacokinetics, Safety and Tolerability of Extended-release Bupropion Hydrochloride Tablets in Chinese Healthy Volunteers
- Nicotine Receptor Density & Response to Nicotine Patch: Pt 2 Extended Treatment
- Naltrexone/Bupropion Cardiovascular Outcomes Study
- Efficacy of Naltrexone HCl/Bupropion HCl Extended Release Versus Placebo for Treatment of Weight Regain in Participants Post Bariatric Surgery
- Bupropion in Sexual Dysfunction Among Methadone Maintenance Treatment Men
- Cytisine Pharmacokinetics and Dose Response (C-DRAKS 3 and C-DRAKS 4)
- Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
- Pharmacokinetic Study of Intranasal Esketamine and Its Effects on the Pharmacokinetics of Orally-Administered Midazolam and Bupropion in Healthy Participants
- Adaptive Pharmacotherapy for Smoking Cessation
- Drug Metabolism and Antidepressant
- Identification of Genetic Markers and Predictors of Antidepressant-induced Suicidality in Youth Depression
- Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia
- CYP2B6 Genetics and Drug Interactions in Healthy Volunteers
- Evaluation of the Potential Pharmacokinetic Interactions Between Probe Drugs in the Geneva Phenotyping Cocktail
- Pharmacovigilance in Gerontopsychiatric Patients
- Drug-Drug Interaction Study: ASP2151 and Bupropion
- Connectivity Affecting the Antidepressant REsponse Study
- Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo
- The Effect of Multiple Doses of BI 187004 on the Single-dose Pharmacokinetics of Repaglinide and Bupropion in Healthy Male Volunteers
- Evaluation of CYP450 Activities in Diabetic Patients vs. Non-diabetic Subjects
- Bioequivalence Study Comparing Naltrexone SR/Bupropion SR Trilayer Tablets From Two Manufacturers
- Abstinence Reinforcement Therapy (ART) for Homeless Veteran Smokers
- Bupropion for Depression in ESRD Patients on Hemodialysis
- Novel Smoking Cessation Drug for Schizophrenia
- Clinical Study of Generic and Brand Bupropion in Depression
- Study to Evaluate the Efficacy, Safety and Tolerability of Bupropion Hydrochloride Extended-release Tablet, and Escitalopram Oxalate Capsule in Subjects With Major Depressive Disorder
- Placebo-controlled Trial of Bupropion for Smoking Cessation in Pregnant Women
- A Comparison of Sustained and Extended Release Bupropion Following Bariatric Surgery
- Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease
- The MATCH (Medication Aids for Tobacco Cessation and Health) Study
- Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder
- Bupropion-Enhanced Contingency Management (CM) for Cocaine Dependence
- Effects of Bupropion in Depression
- A 2-Part Study to Assess Potential Metabolism-Based Drug-Drug Interactions of E2006 When Coadministered With Itraconazole, Rifampin, Midazolam, or Bupropion
- Pharmacokinetic Study of Bupropion Hydrochloride Products With Different Release Patterns
- Optimization of Smoking Cessation Strategies Concurrent With Treatment of Tobacco Related Malignancies
- PRJ2215: Assessment of Buproprion Misuse/Abuse 2004-2011
- Comparison of Depression Identification After Acute Coronary Syndrome: Quality of Life and Cost Outcomes
- Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD
- Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder
- Smoking Cessation for People Living With HIV/AIDS
- Novel Therapeutics in Posttraumatic Stress Disorder (PTSD): A Randomized Clinical Trial of Mifepristone
- Supplemental Transcranial Magnetic Stimulation (TMS) vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study
- A Comparison of Medication Augmentation and PST in the Treatment of Depression in Older Adults
- Study on the Model of Smoking Cessation Intervention and Service Ability Improvement
- Apathy Cure Through Bupropion in Huntington's Disease
- CPT and Smoking Cessation
- Interpersonal Psychotherapy for Treatment Resistant Depression
- Dissemination of a Tailored Tobacco Quitline for Rural Veteran Smokers
- Bupropion for Smoking Cessation in Pregnancy
- Combination Bupropion / Varenicline for Smoking Cessation in Male Smokers
- Contingency Management for Smoking Cessation in Homeless Smokers
- Influence of Bupropion on the Effects of MDMA
- Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients
- Algorithm Guided Treatment Strategies for Major Depressive Disorder
- Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/ Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese Subjects
- Extended Varenicline Treatment for Smoking Among Cancer Patients
- Paroxetine/Bupropion in Depression With Suicide Attempt or Thoughts: fMRI Study
- Novel Therapeutics in Posttraumatic Stress Disorder (PTSD): A Randomized Clinical Trial of Mifepristone
- A Novel Anti-Obesity Drug Combination as a Pharmacotherapy for Cocaine Dependence
- Cocktail Approach for Cytochrome P450 and P-glycoprotein Activity Assessment Using Dried Blood Spot
- An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia
- Varenicline for Nicotine Dependence Among Those With HIV/AIDS
- Combination Treatment Study for Memory Impairment and Depression
- Drug Interaction Study of Multiple Doses of Isavuconazole and a Single Dose of Bupropion
- Bupropion Alone or Combined With Nicotine Gum
- Bupropion SR Plus Counseling for Smoking Cessation
- Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
- Bupropion & Cardio Birth Defect (Slone)
- Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Glycopyrrolate (AIDES-G)
- Using Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Bipolar Depression
- Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With Schizophrenia
- Tailored Smoking Cessation Treatment for LIVE FOR LIFE® Participants
- Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022)
- Neuroimaging Study of Bupropion Treatment in Patients With Major Depressive Disorder
- Clinical Trial to Evaluate the Efficacy of Smoking Cessation
- Cognitive Enhancement as a Target for Cocaine Pharmacotherapy
- Brain Nicotine Receptor Density & Response to Nicotine Patch
- Interventional Study of Wellbutrin XL in Major Depressive Disorder With Atypical Features
- Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
- VA Augmentation and Switching Treatments for Improving Depression Outcomes
- Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression
- Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation
- Bupropion for Smoking Cessation During Pregnancy
- Efficacy And Safety Of Smoking Cessation With Varenicline Tartrate In Diabetic Smokers: (DIASMOKE)
- Electroencephalography (EEG) Signal Processing
- Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study
- Pharmacokinetic Interaction Between Ritonavir and Prasugrel in Healthy Volunteers
- Concurrent Bupropion / Varenicline for Smoking Cessation
- Double-blind, Placebo-Controlled Pilot Study of Bupropion to Promote Smoking Cessation During Pregnancy
- Efficacy Of Bupropion For Attention Deficit Hyperactivity Disorder (ADHD) In Adults
- Symptom Burden in Head and Neck Cancer
- Pilot Study of Tolcapone in Smokers
- Bupropion and Specific Cardiovascular Malformations
- An Open Label Positron Emission Tomography Study in Healthy Male Subjects to Investigate Brain DAT and SERT Occupancy,Pharmacokinetics and Safety of Single Oral Doses of GSK1360707, Using 11C- PE2I and 11C-DASB as PET Ligands
- Varenicline and Smoking Cessation in Schizophrenia
- Carcinogenicity Study of Bupropion
- Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC)
- Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in Smokers
- Bupropion for the Treatment of Apathy in Alzheimer's Dementia
- Bupropion Hydrochloride 300 mg Extended Release Tablets Under Fasting Conditions
- Smoking Cessation Treatment for Methadone Maintenance Patients
- Distribution of Bupropion and Varenicline to Increase Smoking Cessation Attempts
- STOP Study: Effectiveness of Zyban in a Clinical Population
- Varenicline vs Placebo for the Treatment of Methamphetamine Dependence
- Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder
- Pilot Trial of Bupropion Versus Placebo for Methamphetamine Abuse in Adolescents
- Behaviorally Enhanced Counseling on Nicotine Dependence (BEACON) Trial.
- Efficacy and Cost-Effectiveness of Cost-free Pharmacotherapy for Smoking Cessation for High-risk Smokers With Cerebrovascular Disease
- Mood Stabilizer (MS)+ Antidepressant vs MS + Placebo in Maintenance of Bipolar Disorder.
- Combining Varenicline and Bupropion for Smoking Cessation
- Bupropion for ADHD in Adolescents With Substance Use Disorder
- Varenicline and Bupropion for Smoking Cessation
- AZD2066 Cocktail Study
- Effect of Antidepressants on the Treatment for Korean Major Depressive Disorder Patients
- Personalized Indicators for Predicting Response to SSRI Treatment in Major Depression (The PRISE-MD Study)
- To Demonstrate the Relative Bioavailability of Bupropion HCI 100 mg Tablets Under Fasting Conditions
- A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fed Conditions
- A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fasting Conditions
- A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fed Conditions
- A Relative Bioavailability Study of Bupropion Sustained Release 150 mg Tablets Under Fasting Conditions
- A Relative Bioavailability Study of Bupropion HCI 150 mg Sustained-Release Tablets Under Fasting Conditions
- A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fasting Conditions
- To Demonstrate the Relative Bioavailability of Bupropion HCI 300 mg Extended-Release Tablets Under Fasting Conditions
- Varenicline for Smoking Cessation in Heavy Drinking Smokers
- PET Imaging Study on Occupancy of Dopamine D2 Receptors and Genotypes After Bupropion Administration
- Study of Medical Treatment for Methamphetamine Addiction
- Comparative Study of SR Bupropion for Adolescent Smoking Cessation
- Varenicline for the Treatment of Smokeless Tobacco
- Evaluation of Varenicline (Champix) in Smoking Cessation for Patients Post-Acute Coronary Syndrome (EVITA) Trial
- Combination Medications vs. Patch Alone for Medically-Ill Smokers
- Varenicline and Motivational Advice for Smokers With Substance Use Disorders
- Human Laboratory Study of Varenicline and Bupropion for Nicotine Dependence
- A Study Using Functional Magnetic Resonance Imaging (fMRI) to Assess the Effects of Naltrexone SR/ Bupropion SR Therapy in Overweight or Obese Subjects
- Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity
- Zyban as an Effective Smoking Cessation Aid for Patients Following an Acute Coronary Syndrome: The ZESCA Trial
- Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence
- Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
- GABA (Gamma Amino Butyric Acid) Medication for Tobacco
- Predictors of Treatment Response to Fluoxetine in PTSD Following a Recent History of War Zone Stress Exposure
- A Study to Assess the Safety of Repeated Doses of GSK189075 and WELLBUTRIN SR in Healthy Male Subjects
- Nicotine Patch Pretreatment for Smoking Cessation in PTSD
- A Study of Naltrexone SR/ Bupropion SR in Overweight or Obese Subjects With Major Depression
- Bupropion and Restless Legs Syndrome
- Does Sleep Quality Change After Switch From Wellbutrin SR to Wellbutrin XL in Patients With Major Depressive Disorder?
- Effect of Antidepressants on Sex Hormone Levels and Sexual Functioning
- Escitalopram (Lexapro®) In Patients With Major Depression With Atypical Features
- A Preliminary Study of Sustained-Release Bupropion for Smoking Cessation in Bipolar Affective Disorder
- Chantix & Bupropion for Smoking Cessation
- The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior
- Do Treatments for Smoking Cessation Affect Alcohol Drinking?
- Smoking Cessation Intervention for Thoracic Patients
- Bupropion in the Treatment of Methamphetamine Dependence
- A Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects
- Effectiveness of Lithium and Valproate in Treating High-Risk Bipolar Disorder
- A Study of Naltrexone SR/ Bupropion SR in Overweight and Obese Subjects Who Are Nicotine-Dependent
- Bupropion in Helping Adults Stop Smoking
- A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects
- Does Dual Therapy Hasten Antidepressant Response?
- Study of Lunesta Versus Placebo for Sleep Problems Related to Smoking Cessation and Zyban
- Pharmacogenetics, Emotional Reactivity and Smoking
- Role of CYP2B6, CYP3A4, and MDR1 in the Metabolic Clearance of Methadone
- Naltrexone and Varenicline: Weight Gain and Tolerability in Cigarette Smokers
- The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia
- Randomized Trial of Ultrashort Psychotherapy vs Sustained-Release Bupropion for Smoking Cessation
- A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes
- A Safety and Efficacy Study of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects Participating in an Intensive Behavior Modification Program
- Fluoxetine and Bupropion to Treat Patients With Depression and Alcoholism
- Smoking Cessation Program: A Quality Improvement Trial in a Resident-Based Outpatient Clinic
- Paroxetine/Bupropion in Suicide Attempters/Ideators With Major Depression
- Study of Bupropion Versus Bupropion + Naltrexone for Smoking Cessation
- Bupropion SR for Treating Smokeless Tobacco Use
- Craving, Binge Eating and Obesity
- St. John's Wort for Tobacco Cessation
- Dichotic Listening as a Predictor of Medication Response in Depression
- A Brain Imaging Study Into Nicotine Induced Dopamine Release in Cigarette Smokers.
- Efficacy and Safety Study of Combination Therapy to Treat Uncomplicated Obesity
- Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder
- Bupropion Treatment for Youth Smoking Cessation
- Safety and Efficacy of Different Combinations of Zonisamide-CR Plus Bupropion-SR to Treat Uncomplicated Obesity
- Smoking Cessation Medications: Efficacy, Mechanisms and Algorithms
- Study Of Bupropion SR (323U66) In Patients With Major Depressive Disorder In Japan
- Effect of Ethanol and Genetic Polymorphisms on Bupropion Metabolism
- Combined Pharmaco/Behavior Therapy in Adolescent Smokers
- Bio-behavioral Lung Cancer Prevention Program
- Nicotine Replacement Therapy for Smoking Cessation in Schizophrenia
- Smoking Relapse Prevention in Schizophrenia
- Nicotinic Receptor Augmentation of SSRI Antidepressants
- Acceptability of Pharmacologic Treatment for Methamphetamine Dependence Among MSM
- Sexual Functioning Study With Antidepressants
- Nicotine Patch and Bupropion to Reduce Smoking Rates in Younger, Low-Income, and Minority Individuals
- Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke
- Effectiveness of Bupropion for Smokers Recovering From Alcohol Dependence
- Memory Functioning and Antidepressant Treatment
- Treatment of Depression Following Multiple Brain Tests
- Are Two Antidepressants a Good Initial Treatment for Depression?
- Smoking Cessation Intervention: Effectiveness in Primary Care
- Bupropion For Reducing High-Risk Behaviors in Depressed Men Who Have Sex With Men (MSM)
- Assessment of Bupropion on Cognitive Function and Behaviour in Healthy Volunteers
- Safety and Efficacy Study of Topiramate to Aid in Smoking Cessation
- The Effects of Craving and Abstinence From Cigarettes on Brain Metabolism in Smokers
- Bupropion for Hospital-Based Smoking Cessation
- Effectiveness of Nefazodone and Bupropion in Treating Marijuana Dependent Individuals
- Female Orgasmic Disorder (FOD) and Wellbutrin XL
- Efficacy and Safety of Bupropion for Treatment of Adolescent Smoking
- A Feasibility Study of Smoking Cessation Program in Radiation Oncology
- Wellbutrin XL, Major Depressive Disorder and Breast Cancer
- Integrated Treatment for Cocaine and Mood Disorders - 1
- Effectiveness of GW468816, an NMDA Glycine Site Antagonist, for Prevention of Relapse to Smoking
- Effect of Bupropion on Smoking Behavior in Smokers With Schizophrenia
- Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia
- Abilify Therapy for Reducing Comorbid Substance Abuse
- The Effects of Acute Administration of Bupropion on Neural Substrates Underlying Hedonic Capacity
- Treatment of Nicotine Dependence and Acute Depression
- Bupropion SR for Major Depression and Depression NOS in Children and Adolescents With Bipolar Disorder
- Bupropion for Hospitalized Smokers With Acute Cardiovascular Disease
- Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression
- Dynamic Measures of Neurochemistry in Mood Disorders
- Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study
- A Comparison of Bupropion SR and Placebo for Smoking Cessation
- Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1
- Effectiveness of Bupropion in Treating Marijuana Dependent Individuals
- Bupropion as an Adjunct to the Nicotine Patch Plus CBT
- Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals - 3
- Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia
- The Effects of Memantine and Bupropion on Acute, Reinforcing, and Conditioned Effects of Cigarettes - 1
- Effectiveness of Bupropion Combined With Behavioral Therapy for Treating Methamphetamine Dependence - 2
- Use of Pharmacotherapy to Reduce Cue-responsiveness in Smokers
- Impact of Smoking Cessation on Sleep - 5
- Usefulness of Selegiline as an Aid to Quit Smoking - 1
- Effectiveness of Bupropion for Treating Nicotine Dependence in Young People
- Low-Dose Naltrexone Combined With Bupropion to Stop Smoking With Less Weight Gain
- A Trial of Wellbutrin for Crohn's Disease
- The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression
- ISTAPS: A Stepped Primary Care Smoking Cessation Intervention
- Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1
- Pilot Study of Bupropion for Smoking Cessation in Postpartum Non-breastfeeding Women
- Non-Nicotine Agents for Smoking Cessation
- Hormone and Sleep Response to Antidepressant Treatment in Adolescents and Adults With Depression
- Framing Messages for Smoking Cessation With Bupropion - 6
- Major Depressive Disorder In The Elderly
- Comparing Smoking Treatment Programs for Lighter Smokers - 1
- Treatment of Adolescent Suicide Attempters (TASA)
- Bupropion and Counseling With or Without Contingency Management to Enhance Smoking Cessation in Treating Cancer Survivors Who Continue to Smoke
- Seasonal Affective Depression (SAD) Study
- Bupropion for the Treatment of Methamphetamine Dependence - 1
- Lethargic Depression Study
- Maintenance Treatment for Abstinent Smokers
- Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1
- Bupropion in the Treatment of Pathological Gambling
- Effects Of Antidepressants On Sexual Functioning In Adults
- Effects of Antidepressants on Sexual Functioning
- Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults
- Prevention of Seasonal Affective Disorder
- Bupropion as a Smoking Cessation Aid in Alcoholics
- Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1
- Comparison of Nicotine Inhaler and/or Bupropion in Helping People to Stop Smoking and Prevent the Recurrence of Smoking
- S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery
- Sequenced Treatment Alternatives to Relieve Depression (STAR*D)
- Combinations of Pharmacologic Smoking Cessation Treatments
- Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
- Bupropion and Weight Control for Smoking Cessation - 1
- Acute Effectiveness of Additional Drugs to the Standard Treatment of Depression
- Pharmacologic Relapse Prevention for Alcoholic Smokers
- Dopamine Reuptake Inhibitors of Cocaine Abuse - 1
- Cocaine Abuse and Attention Deficit Disorder - 3
Clinical trials list
click for details